Gilead Sciences Announces Fourth Quarter 2020 Dividend
October 28 2020 - 4:02PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the
company’s Board of Directors has declared a cash dividend of $0.68
per share of common stock for the fourth quarter of 2020. The
dividend is payable on December 30, 2020, to stockholders of record
at the close of business on December 15, 2020. Future dividends
will be subject to Board approval.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information about Gilead Sciences,
please visit the company’s website at www.gilead.com, follow Gilead on Twitter
(@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5
or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201028005956/en/
Investors Adam Levy, MBA,
Ph.D. (650) 574-3000
Douglas Maffei, Ph.D. (650) 574-3000
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024